Your browser doesn't support javascript.
loading
Anti-CD22 epratuzumab for systemic lupus erythematosus: A systematic review and meta-analysis of randomized controlled trials.
Li, Jian; Wei, Ming-Ming; Song, Qin; Guo, Xiang-Hua; Shao, Li; Liu, Yan.
Afiliação
  • Li J; Department of Rheumatology and Immunology, Affiliated Hospital of Jining Medical University, Jining, Shandong 272000, P.R. China.
  • Wei MM; Department of Nephrology, Affiliated Hospital of Jining Medical University, Jining, Shandong 272000, P.R. China.
  • Song Q; Department of Rheumatology and Immunology, Affiliated Hospital of Jining Medical University, Jining, Shandong 272000, P.R. China.
  • Guo XH; Department of Rheumatology and Immunology, Affiliated Hospital of Jining Medical University, Jining, Shandong 272000, P.R. China.
  • Shao L; Department of Rheumatology and Immunology, Affiliated Hospital of Jining Medical University, Jining, Shandong 272000, P.R. China.
  • Liu Y; Department of Rheumatology and Immunology, Affiliated Hospital of Jining Medical University, Jining, Shandong 272000, P.R. China.
Exp Ther Med ; 18(2): 1500-1506, 2019 Aug.
Article em En | MEDLINE | ID: mdl-31316634
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Idioma: En Ano de publicação: 2019 Tipo de documento: Article